Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,117.00
+2.00 (0.18%)
Sep 21, 2025, 3:49 PM IDT
TLV:REKA Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -13.45 | 6.21 | -6.91 | -2.04 | 6.62 | 10.8 | Upgrade |
Depreciation & Amortization | 31.84 | 32.52 | 29.84 | 27.48 | 22.86 | 19.71 | Upgrade |
Other Amortization | 0.14 | 0.14 | 0.08 | - | - | - | Upgrade |
Loss (Gain) From Sale of Assets | 0 | -23.44 | 0.05 | -0 | -0.05 | -0.03 | Upgrade |
Loss (Gain) From Sale of Investments | -0.12 | -0.23 | 0.04 | -0.04 | -1.19 | - | Upgrade |
Loss (Gain) on Equity Investments | 0.09 | -0.01 | 0.22 | - | 0.13 | 0.64 | Upgrade |
Stock-Based Compensation | -0.09 | -0.14 | 0.19 | 0.4 | 0.45 | 0.1 | Upgrade |
Other Operating Activities | -0.64 | -3.53 | 0.2 | 5.31 | 0.21 | 0.43 | Upgrade |
Change in Accounts Receivable | -4.08 | -8.51 | 6.8 | -14.56 | -14.4 | -10.2 | Upgrade |
Change in Inventory | 5.05 | 14.12 | 2.91 | -2.59 | 13.19 | -28.66 | Upgrade |
Change in Accounts Payable | -14.94 | 5.98 | -2.19 | 26.81 | -3.83 | 14.7 | Upgrade |
Change in Income Taxes | 1.84 | 3.48 | -0.09 | -2.19 | -1.35 | 0.87 | Upgrade |
Change in Other Net Operating Assets | 3.73 | -0.05 | -2.77 | 0.42 | -1.47 | 2.94 | Upgrade |
Operating Cash Flow | 9.36 | 26.54 | 28.35 | 39 | 21.17 | 11.28 | Upgrade |
Operating Cash Flow Growth | -61.22% | -6.38% | -27.31% | 84.24% | 87.62% | -66.73% | Upgrade |
Capital Expenditures | -7.83 | -8.69 | -11.49 | -6.93 | -13.49 | -18.63 | Upgrade |
Sale of Property, Plant & Equipment | 0.43 | 30 | 0.06 | 0.03 | 0.13 | 0.09 | Upgrade |
Cash Acquisitions | - | - | -9.79 | -6 | -25.34 | - | Upgrade |
Sale (Purchase) of Intangibles | -0.01 | -0.01 | -0.32 | -0.55 | -0.51 | -0.21 | Upgrade |
Investment in Securities | 0.48 | 0.15 | 0.04 | - | 3.65 | - | Upgrade |
Other Investing Activities | - | -6.16 | - | - | -0.35 | - | Upgrade |
Investing Cash Flow | -6.92 | 15.29 | -21.5 | -13.45 | -35.9 | -18.74 | Upgrade |
Short-Term Debt Issued | - | 11.35 | 3 | - | - | 5 | Upgrade |
Long-Term Debt Issued | - | 3 | 38 | 10 | 40 | 40 | Upgrade |
Total Debt Issued | 26.35 | 14.35 | 41 | 10 | 40 | 45 | Upgrade |
Short-Term Debt Repaid | - | - | - | -0.01 | -4.99 | - | Upgrade |
Long-Term Debt Repaid | - | -66.73 | -35.74 | -24.35 | -37.78 | -25.92 | Upgrade |
Total Debt Repaid | -29.97 | -66.73 | -35.74 | -24.36 | -42.78 | -25.92 | Upgrade |
Net Debt Issued (Repaid) | -3.62 | -52.38 | 5.26 | -14.36 | -2.78 | 19.08 | Upgrade |
Common Dividends Paid | - | - | - | -10 | - | - | Upgrade |
Other Financing Activities | -1.3 | -1.76 | -13.05 | - | - | - | Upgrade |
Financing Cash Flow | -4.92 | -54.13 | -7.78 | -24.36 | -2.78 | 19.08 | Upgrade |
Foreign Exchange Rate Adjustments | -0.01 | 0.03 | 0.03 | 0.41 | -0.78 | -0.3 | Upgrade |
Net Cash Flow | -2.48 | -12.28 | -0.9 | 1.61 | -18.29 | 11.33 | Upgrade |
Free Cash Flow | 1.53 | 17.85 | 16.86 | 32.07 | 7.68 | -7.35 | Upgrade |
Free Cash Flow Growth | -87.46% | 5.86% | -47.42% | 317.44% | - | - | Upgrade |
Free Cash Flow Margin | 0.49% | 5.55% | 5.24% | 10.97% | 2.91% | -2.77% | Upgrade |
Free Cash Flow Per Share | 0.13 | 1.56 | 1.48 | 2.81 | 0.67 | -0.64 | Upgrade |
Cash Interest Paid | 6.76 | 7.25 | 8.55 | 5.69 | 5.74 | 6.42 | Upgrade |
Cash Income Tax Paid | 9.3 | 9.4 | 0.99 | 6.1 | 3.77 | 1.33 | Upgrade |
Levered Free Cash Flow | -2.87 | 37.27 | 12.23 | 33.25 | -0.51 | -11.03 | Upgrade |
Unlevered Free Cash Flow | 1.12 | 41.46 | 17.42 | 36.78 | 3.01 | -7.4 | Upgrade |
Change in Working Capital | -8.4 | 15.02 | 4.65 | 7.9 | -7.87 | -20.36 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.